SciCombinator

Discover the most talked about and latest scientific content & concepts.

Abstract
Effective treatment of reactive arthritis would ideally achieve both control of inflammation and eradication of persisting arthritogenic pathogens. We use a model of experimental Chlamydia trachomatis-induced arthritis (CtIA) to evaluate the effectiveness of nafamostat mesilate (NM), a serine protease inhibitor with complement-modifying effects and anticoagulant properties. To date clinical use of NM has largely been in Asia and has been primarily confined to inflammatory states such as pancreatitis.
Tweets*
2
Facebook likes*
0
Reddit*
0
News coverage*
0
Blogs*
0
SC clicks
1
Concepts
Mesylate, Microbiology, Reactive arthritis, Clinical trial, Effect, Effectiveness, Serine protease, Protease
MeSH headings
-
comments powered by Disqus

* Data courtesy of Altmetric.com